United States · 
Who invested in Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals's investors include Redmile Group, New Leaf Venture Partners, Viking Global and Sphera Global/ New Leaf.
20162017
$75MSeries B$52MSeries C
United States · Series C startup
Who invested in Deciphera Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$127Mraised across 2 rounds since 2015, from 2 sources
$75MSeries B$52MSeries C
- Latest round
- Series C, $52MJun 2017
- Biggest round
- $75MSeries B · Sept 2015
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $75M Sept 2015
- Biggest round
- $75M Series B · Sept 2015
- Between rounds
- 20 months from the last two
The rounds
- Jun 2017Series C$52M3 new
Redmile Group
Viking Global- Sphera Global/ New Leaf
Reported by FinSMEsSEC filing: $52M sold, first sale May 2017
- Sept 2015Series B$75M1 new
From a historical funding recordSEC filing: $22M sold, first sale Sept 2015
Founders and team
From Deciphera Pharmaceuticals's own website and the SEC filings it signed: 12 on the team.
- Ryota UdagawaPresident & Chief Executive Officer
- Annah LitzenbergerChief Human Resources Officer
- Masahiro HamadaChief of Staff
- Akira ImagawaHead of Research
- Jennifer StrongHead of Technical Operations
- Peter HaburaHead of Quality Assurance and Pharmacovigilance
- Maria OstrovskyGeneral Counsel
- Christopher J. MorlExecutive Officeri
- Daniel L. FlynnExecutive Officeri
- Michael D. TaylorExecutive Officer, Directori
- Oliver L. RosenExecutive Officeri
- Thomas L. KellyExecutive Officeri
On the board, as filediDennis A. WalshEdward J. BenzJames A. BristolJohn A. MartinLiam A. RatcliffeMichael A. RossPatricia L. Allen
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Sphera Global/ New Leafno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Deciphera Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Deciphera Pharmaceuticals
How much has Deciphera Pharmaceuticals raised?
Deciphera Pharmaceuticals has raised $127M across 2 rounds since 2015.
When did Deciphera Pharmaceuticals last raise?
Deciphera Pharmaceuticals's most recent round was a Series C of $52M in Jun 2017.
What was Deciphera Pharmaceuticals's biggest round?
Deciphera Pharmaceuticals's largest round on record is $75M (Series B), in Sept 2015.
Who backed Deciphera Pharmaceuticals first?
Deciphera Pharmaceuticals's first round on record, in Sept 2015, was backed by New Leaf Venture Partners.
What stage is Deciphera Pharmaceuticals at?
Deciphera Pharmaceuticals's latest named round is a Series C, in Jun 2017.
Where is Deciphera Pharmaceuticals based?
Deciphera Pharmaceuticals is based in the United States.
Companies like Deciphera Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.